ERBB2 and small cell lung carcinoma: Motivated by the finding that ERBB2 blockade induces MHC-I expression, we applied a fully autochthonous SCLC mouse model to investigate the impact of drug-induced ERBB2 inhibition on SCLC immune cell evasion and metastasis (Fig. 6a).